Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
gptkb:1993
|
| gptkbp:available_in |
various strengths
|
| gptkbp:available_on |
gptkb:tablet
suspension gel cap |
| gptkbp:brand |
gptkb:Aleve
Anaprox Naprelan Naprosyn |
| gptkbp:category |
Category C
|
| gptkbp:condition |
gptkb:juvenile_idiopathic_arthritis
fever tendinitis back pain headaches bursitis muscle aches toothaches gout menstrual cramps |
| gptkbp:contraindication |
severe heart failure
severe liver disease severe kidney disease active peptic ulcer allergy to naproxen |
| gptkbp:dosage_form |
oral
220 mg every 8 to 12 hours 660 mg per day |
| gptkbp:formulation |
over-the-counter
prescription |
| https://www.w3.org/2000/01/rdf-schema#label |
Aleve
|
| gptkbp:ingredients |
naproxen
|
| gptkbp:interacts_with |
gptkb:methotrexate
gptkb:ACE_inhibitors gptkb:warfarin lithium diuretics |
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:side_effect |
dizziness
headache nausea stomach pain |
| gptkbp:storage |
room temperature
away from moisture away from heat |
| gptkbp:used_for |
pain relief
inflammation reduction fever reduction |
| gptkbp:bfsParent |
gptkb:Midol
gptkb:Bayer_Consumer_Health |
| gptkbp:bfsLayer |
6
|